News
Omron and Tricog launch KeeboHealth to combat India’s cardiac crisis and drive ‘Going for Zero’ vision: Our Bureau, Bengaluru ...
Karnataka government assigns licensing authority role to Dr Umesh S, additional drugs controller of state FDA: Our Bureau, Bengaluru Friday, July 11, 2025, 12:15 Hrs [IST] Karnata ...
MedLern offers comprehensive e-learning platform for NABH 6th edition standards: Our Bureau, Bengaluru Friday, July 11, 2025, 12:30 Hrs [IST] MedLern, India's leading full-stack h ...
MAIA Biotechnology enrolls first patient in expansion of phase 2 clinical trial for ateganosine in advanced non-small cell lung cancer: Chicago Friday, July 11, 2025, 12:00 Hrs [I ...
Delhi High Court asks CCSEA to conduct inspection on Palamur Biosciences: Our Bureau, New Delhi Friday, July 11, 2025, 11:30 Hrs [IST] The Delhi High Court has asked the Committee ...
Bayer seeks European marketing authorization for investigational contrast agent, gadoquatrane: Berlin Friday, July 11, 2025, 11:00 Hrs [IST] Bayer announced the submission of a ma ...
MedTech zone innovative programme selected for BRICS+ Global Initiative: Our Bureau, Mumbai Thursday, July 10, 2025, 14:20 ...
Lone Tree, Colorado Thursday, July 10, 2025, 13:00 Hrs [IST] ...
Small pharma cos struggle with revised Schedule M compliance amid resource & expertise gaps: Harish Jain: Nandita Vijayasimha, Bengaluru Friday, July 11, 2025, 08:00 Hrs [IST] Sma ...
Karnataka and Germany sign MoU to strengthen ties in lifesciences start-ups: Nandita Vijayasimha, Bengaluru Friday, July 11, 2025, 08:00 Hrs [IST] ed by Minister M?B?Patil and Dr?
The Central Drugs Standard Control Organisation (CDSCO) has published a prerequisite form for the industry members to fill in for the walk-in meeting with the Drugs Controller General of India (DCGI) ...
In a move aimed at boosting pharma exports and enhancing transparency in international trade, the Directorate General of Foreign Trade (DGFT) has announced the introduction of new Standard Input ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results